CTO and Co-founder​

Scott has over 20 years of drug discovery and development experience, holding positions in both biotech and academia. He is Professor of Medicines Discovery at the Centre for Cardiovascular Science, University of Edinburgh where, for more than a decade, he has specialised in translational research focused on discovering and developing small molecules as potential medicines. Scott has previously discovered and advanced therapeutics through preclinical discovery and first time in human clinical development, successfully licensing assets for pivotal proof of concept studies in patients. Scott received his PhD in Chemistry from the University of Edinburgh.​

LinkedIn